Please Wait
Applying Filters...
menu
    • menu
    Kewpie-PSE
    News
    Consolidated business results for fiscal year ended Nov 30 2024

    09 Jan 2025

    // PRESS RELEASE

    Supplementary Data for the FY Ended Nov 30 2024

    09 Jan 2025

    // PRESS RELEASE

    Notice regarding Formulation of Medium-Term Business Plan

    25 Nov 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Kewpie Corporation

    Contact Supplier

    Website

    CPhI Japan

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/a9474wUfYEQ
    Menu

    Kewpie Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Hyaluronic Acid

    02 1Sodium Hyaluronate

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Hyaluronic Acid

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients. Its Sodium hyaluronate is suitable for injections, eye drops and external preparations. Its pharmaceutical grade Sodium hyaluronate (Hyaluronic acid) is manufac...
    Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients. Its Sodium hyaluronate is suitable for injections, eye drops and external preparations. Its pharmaceutical grade Sodium hyaluronate (Hyaluronic acid) is manufactured at its factory near Tokyo under strict regulations. Since 2016, Kewpie has developed and manufactured medical devices using Sodium hyaluronate. Its R&D team can also provide Sodium hyaluronate derivatives as per clients’ needs. Kewpie exports Sodium hyaluronate to over 30 countries.
    Kewpie Company Banner

    01

    Hyaluronic Acid

    Japan
    arrow
    CPhI Japan
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Kewpie Corporation

    Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients. Its Sodium hyaluronate is suitable for injections, eye drops and external preparations. Its pharmaceutical grade Sodium hyaluronate (Hyaluronic acid) is manufactured at its factory near Tokyo under strict regulations. Since 2016, Kewpie has developed and manufactured medical devices using Sodium hyaluronate. Its R&D team can also provide Sodium hyaluronate derivatives as per clients’ needs. Kewpie exports Sodium hyaluronate to over 30 countries.

    About the Company : Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients. Its ...

    Kewpie Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Sodium Hyaluronate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients. Its Sodium hyaluronate is suitable for injections, eye drops and external preparations. Its pharmaceutical grade Sodium hyaluronate (Hyaluronic acid) is manufac...
    Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients. Its Sodium hyaluronate is suitable for injections, eye drops and external preparations. Its pharmaceutical grade Sodium hyaluronate (Hyaluronic acid) is manufactured at its factory near Tokyo under strict regulations. Since 2016, Kewpie has developed and manufactured medical devices using Sodium hyaluronate. Its R&D team can also provide Sodium hyaluronate derivatives as per clients’ needs. Kewpie exports Sodium hyaluronate to over 30 countries.
    Kewpie Company Banner

    02

    Sodium Hyaluronate

    Japan
    arrow
    CPhI Japan
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Kewpie Corporation

    Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients. Its Sodium hyaluronate is suitable for injections, eye drops and external preparations. Its pharmaceutical grade Sodium hyaluronate (Hyaluronic acid) is manufactured at its factory near Tokyo under strict regulations. Since 2016, Kewpie has developed and manufactured medical devices using Sodium hyaluronate. Its R&D team can also provide Sodium hyaluronate derivatives as per clients’ needs. Kewpie exports Sodium hyaluronate to over 30 countries.

    About the Company : Kewpie first developed Sodium hyaluronate in 1983 and is currently the leading Japanese manufacturer of pharmaceutical grade Sodium hyaluronate used as an API and pharmaceutical excipients. Its ...

    Kewpie Company Banner

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Kewpie Corporation and get a quotation

    Kewpie Corporation is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find a price of Sodium Hyaluronate bulk with DMF, CEP, JDMF offered by Kewpie Corporation

    Find a price of Sodium Hyaluronate bulk with DMF, JDMF offered by Kewpie Corporation

    Find a price of Hyaluronic Acid bulk with JDMF offered by Kewpie Corporation

    Find a price of Sodium Hyaluronate bulk with JDMF offered by Kewpie Corporation